ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Recruiting

Phase 1

Phase 2

ATSN-201 Gene Therapy in RS1-Associated X-linked RetinoschisisATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Sponsor:

Atsena Therapeutics Inc.

Code:

NCT05878860

Conditions

X-linked Retinoschisis

Eligibility Criteria

Sex: Male

Age: 6+

Healthy Volunteers: Not accepted

Interventions

ATSN-201

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information